NOTES PAYABLE RELATED PARTIES (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 03, 2023 |
Dec. 08, 2022 |
Nov. 01, 2022 |
Jun. 08, 2022 |
Sep. 09, 2021 |
Mar. 16, 2023 |
Jan. 22, 2013 |
Jun. 30, 2023 |
Jun. 30, 2022 |
Jun. 30, 2023 |
Jun. 30, 2022 |
Dec. 31, 2022 |
|
Common stock shares issued | 517,001 | |||||||||||
Per share value | $ 0.001 | $ 0.001 | $ 0.001 | |||||||||
Loss on settlement of debt | $ (34,338) | $ 0 | $ (34,338) | $ 0 | ||||||||
Interest expense - related parties | 162,825 | 372,118 | 332,205 | 525,618 | ||||||||
Interest expense amortization | 118,554 | 118,554 | 233,888 | 233,888 | ||||||||
Interest expense | $ 86,821 | 27,489 | 100,326 | 53,529 | 113,602 | |||||||
Notes payable | 359,729 | 359,729 | $ 297,602 | |||||||||
Louis Lucido [Member] | ||||||||||||
Outstanding Promissory Note | $ 300,000 | 0 | 300,000 | 0 | 300,000 | |||||||
Unsecured promissory notes | $ 300,000 | 20,000 | ||||||||||
Common stock shares issued | 183,606 | 33,000 | ||||||||||
Per share value | $ 1.71 | |||||||||||
Loss on settlement of debt | $ (34,338) | $ 34,000 | ||||||||||
Interest expense - related parties | 162,825 | 372,118 | 332,205 | 525,618 | ||||||||
Accrued Interest | $ 13,892 | |||||||||||
Outstanding Balance | 20,000 | 20,000 | ||||||||||
Accumulated Interest Notes Payable | 401,857 | 401,857 | 332,567 | |||||||||
Interest rate during period | 5.00% | |||||||||||
Debt discount interest expense | $ 25,400 | 488 | 15,135 | |||||||||
Interest payment | 3,750 | |||||||||||
Stock issued during period, value | $ 59,400 | |||||||||||
Interest expense | 7,687 | 11,386 | ||||||||||
Proceed from advances | $ 55,000 | $ 50,000 | ||||||||||
Notes payable | $ 55,000 | 50,000 | 50,000 | |||||||||
Lourdes Felix [Member] | ||||||||||||
Proceed from advances | 133,273 | |||||||||||
Notes payable | 98,273 | 98,273 | ||||||||||
Kent Emry [Member] | ||||||||||||
Unsecured promissory notes | $ 500,000 | $ 200,000 | ||||||||||
Interest rate | 12.00% | |||||||||||
Interest rate during period | 25.00% | |||||||||||
Interest expense | $ 214,975 | 31,164 | $ 31,164 | 61,986 | $ 61,986 | |||||||
Notes payable | 500,000 | $ 500,000 | $ 500,000 | |||||||||
Warrant exercise price | $ 4.14 | |||||||||||
Fair value of warrants | $ 214,975 | |||||||||||
Warrant issue | 119,617 | 119,617 | 119,617 | |||||||||
Due from related party | $ 1,500 | $ 1,500 | ||||||||||
Outstanding principal balance on issuance of promissory note | $ 163,610 | $ 163,610 | ||||||||||
Principal payments (monthly) | $ 6,650 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Increase for accrued, but unpaid interest on the debt instrument for the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The average effective interest rate during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of the required periodic payments including both interest and principal payments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Interest and debt related expenses associated with nonoperating financing activities of the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of cash inflow from collection of advance by Federal Home Loan Bank (FHLBank), classified as investing activity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|